Strontium ranelate stimulates the activity of bone-specific alkaline phosphatase: interaction with Zn2+ and Mg2+

Strontium ranelate prevents the deleterious action of advanced glycation endproducts on osteoblastic cells via calcium channel activation

(2013) Juan Manuel Fernández et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Antibacterial and biological characteristics of silver containing and strontium doped plasma sprayed hydroxyapatite coatings

(2012) Gary A. Fielding et al.   Acta Biomaterialia

Strontium signaling: Molecular mechanisms and therapeutic implications in osteoporosis

(2012) Zuzana Saidak et al.   PHARMACOLOGY & THERAPEUTICS

Increased strontium uptake in trabecular bone of ovariectomized calcium-deficient rats treated with strontium ranelate or strontium chloride

(2011) Bernhard Pemmer et al.   JOURNAL OF SYNCHROTRON RADIATION

The intact strontium ranelate complex stimulates osteoblastogenesis and suppresses osteoclastogenesis by antagonizing NF-κB activation

(2011) Masayoshi Yamaguchi et al.   MOLECULAR AND CELLULAR BIOCHEMISTRY

The Calcium-sensing Receptor (CaR) is Involved in Strontium Ranelate-induced Osteoblast Differentiation and Mineralization

(2010) S. Takaoka et al.   HORMONE AND METABOLIC RESEARCH

Strontium Ranelate Decreases Receptor Activator of Nuclear Factor- B Ligand-Induced Osteoclastic Differentiation In Vitro: Involvement of the Calcium-Sensing Receptor

(2010) A. Caudrillier et al.   MOLECULAR PHARMACOLOGY

Mineralization density distribution of postmenopausal osteoporotic bone is restored to normal after long-term alendronate treatment: qBEI and sSAXS data from the fracture intervention trial long-term extension (FLEX)

(2009) P Roschger et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Effective doses for strontium ranelate

(2008) P. J. Marie   OSTEOPOROSIS INTERNATIONAL

Calculating clinically relevant drug doses to use in animal studies

(2008) R. K. Fuchs et al.   OSTEOPOROSIS INTERNATIONAL